BTBurcu Nurozler Tabakci

Burcu Nurozler Tabakci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Burcu Nurozler Tabakci has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neurotrophic effects of topical insulin in persistent epithelial defects

    by Irem Onal, Fahri Onur Aydin, Yusuf Berk Akbas, Ali Ceylan, Emre Avci, Burcu Nurozler Tabakci, Burcin Kepez Yildiz

    Purpose To evaluate the effect of topical insulin eye drops in promoting epithelial healing in patients with neurotrophic keratopathy (NK) and persistent epithelial defects (PED), and to assess their impact on corneal sensitivity as an indicator of neurotrophic function. Methods This retrospective study included 24 patients with PED unresponsive to standard medical and surgical treatment. Patients received topical insulin eye drops (1 IU/mL) every six hours for one month. Corneal sensitivity, measured with Cochet-Bonnet esthesiometer, and PED size were recorded at baseline, and at 1st, 2nd week and 1st month after treatment initiation. Results The most common underlying etiology was epithelial debridement during vitrectomy and NK due to herpes simplex virus (n=6, 25.0% each), followed by chemical injury (n=4, 16.6%). While the initial epithelial defect area was 16.23±11.23 mm2, the defect area at 1 month after initiating insulin eye drops was 0.63±1.27 (p=0.0019). Corneal sensitivity values showed improvement in all quadrants one month post-treatment (central, p=0.002; superior, ppp=0.002; temporal, p=0.001). Following treatment, recurrence was noted in 2 cases, while 6 patients showed a partial response. In 3 of these partial responders, isolated hyperkeratinized epithelial islands were identified. The mean duration of insulin drop use was 45.6±15.3 days, and the mean time to complete epithelial defect closure was 22.7±12.8 days. A mean total follow-up duration was 172.0 ± 71.7 days. Conclusion Topical insulin promotes epithelial healing in PED and may improve functional corneal sensitivity, potentially reflecting enhanced corneal neurotrophic function. Its accessibility and favorable safety profile make it a promising therapeutic option.

  • Effects of blue-violet light filtering and surface technologies on visual performance: a retrospective clinical comparison using daily silicone hydrogel contact lenses

    by Seda Duran Güler, Serkan Güler, Burcu Nurözler Tabakçı, Burçin Kepez Yıldız

    Blue-violet light-filtering daily contact lenses are becoming more popular as a way of addressing the visual challenges associated with prolonged exposure to digital screens and low-light environments. Optimising contrast sensitivity in such situations is important for visual comfort, functional performance and patient satisfaction, especially among individuals with high visual demands or frequent exposure to glare. Digital device use has increased exposure to short-wavelength light, contributing to visual fatigue and reduced contrast sensitivity. Blue-violet - filtering soft contact lenses have been developed to enhance visual performance; however, independent clinical data comparing such lenses to non-filtering designs manufactured from the same material remain limited. This retrospective comparative study analysed 45 myopic adults fitted with two senofilcon-A daily disposable lenses: OASYS (non-filtering) and MAX (blue-violet filtering). Contrast sensitivity (photopic, mesopic, glare), corneal aberrations, and non-invasive tear break-up time (NIBUT) were assessed. Repeated-measures ANOVA and regression analyses were used to evaluate lens-related differences and identify predictors of contrast sensitivity. MAX lenses demonstrated significantly higher contrast sensitivity at medium-to-high spatial frequencies under photopic and mesopic conditions, and at low-to-mid frequencies with glare. Tear-film stability was preserved with both lenses without clinically meaningful differences. Corneal aberration changes were small; higher coma and trefoil values correlated with reduced contrast sensitivity during MAX wear. No demographic or pupil-related factors influenced outcomes. Blue-violet - filtering MAX lenses provide measurable improvements in contrast sensitivity, particularly under low light and glare. While tear-film stability remained comparable between lenses, optical design features of the MAX lens contributed to enhanced visual performance. These findings support their use in patients with high digital-screen exposure or night-time visual demands.

  • Open Access

    The impact of various daily disposable contact lens materials on contrast sensitivity

    by Burcu Nurözler Tabakci, Seda Duran Güler, Gül Varan, Petek Aksöz, Yusuf Yildirim

    Purpose: This study aimed to compare the effects of three different daily disposable contact lens materials on contrast sensitivity. Methods: The participants were aged 18-45 years, with spherical equivalent refraction between -0.50 D and -6.00 D, astigmatism below 0.75 D, and best contact lens-corrected visual acuity of 0.0 logMAR or better. Each patient was fitted binocularly with three daily disposable contact lenses made of different materials on three separate examination days. These materials were kalifilcon A, senofilcon A, and verofilcon A. The contrast sensitivity of each patient was recorded at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd) under photopic (85 cd/m2) and mesopic (3 cd/m2) conditions. Results: The current study comprised 72 eyes of 34 female and two male patients. The mean age of the participants was 25.63 (± 0.80) years. Under photopic conditions, the participants’ contrast sensitivity was significantly better with senofilcon A than with kalifilcon A at a frequency of 12 cpd (p=0.008). Under mesopic conditions, participants’ contrast sensitivity was significantly higher with kalifilcon A than verofilcon A at 3 cpd (p=0.001), and with senofilcon A than verofilcon A at 12 cpd (p=0.004). The pre-lens non-invasive break-up times did not differ significantly between the three daily disposable contact lenses (p>0.05). Conclusion: In both photopic and mesopic lighting conditions, the participants in this study exhibited differences in contrast sensitivity when wearing three different daily disposable contact lens types, despite similar visual acuity and pre-lens tear film stability results in their clinical evaluations. These findings demonstrate the potential for subjective visual complaints arising from variations in the contrast sensitivity achieved by different daily disposable contact lenses.

  • Long-term ocular surface stability in conjunctivolimbal autograft and ocular surface safety in the donor eyes

    by Burcu Nurozler Tabakci, Ayşe Burcu, Züleyha Yalnız Akkaya, Evin Şıngar, Selma Ozbek-Uzman, Firdevs Örnek

    Purpose The current study is aimed to present the long-term results of the patients who underwent conjunctivolimbal autograft (CLAU) as the primary operation in unilateral limbal stem cell deficiency and the ocular surface safety of the donor eyes. The patients were followed up for five years or longer. Methods The records of all patients who underwent CLAU as the primary operation were retrospectively analyzed. Additional ocular surface operations, ocular surface stability, best-corrected visual acuity (BCVA), and ocular surface status of the donor eyes were investigated. Results The mean age of the patients at the time of transplantation was 35.07 ± 12.9 (12–60). Twenty-nine eyes of 29 patients were followed up for an average of 97.82 ± 34.45 (60–186) months. Additional ocular surface operation was required in 27.58% (8/29) of the eyes in order to achieve a stable ocular surface. Ocular surface stability was achieved in 82.75% (24/29) of the eyes at the end of the follow-up period. BCVA increased from 1.78 ± 0.82 to 0.91 ± 0.92 logMAR at the last visit (p < 0.001). Corneal ectasia and vascularization developed in one donor eye in the fifth postoperative year. Conclusions CLAU tissues provide ocular surface stability with a successful vision result in the long term. CLAU theoretically carries risks including limbal stem cell deficiency in the donor eye. In the long-term follow-up of donor eyes after CLAU, ectasia and limbal stem cell deficiency were observed in one eye.


  • Cataract surgery after lamellar wedge resection in advanced pellucid marginal degeneration: a case report

    by Burcu Nurozler Tabakci, Ayse Burcu, Evin Singar, Zuleyha Yalniz Akkaya, Selma Uzman Ozbek, Firdevs Ornek

  • Clinical outcome comparison: bilateral trifocal vs. mix–match extended depth of focus and trifocal intraocular lenses

    by Banu Acar, Burcu Nurozler Tabakci

    Purpose To analyze the visual outcomes, contrast sensitivity (CS), and patient satisfaction differences between the bilateral implantation of a trifocal intraocular lens (IOL) and the mix–match implantation of an extended-depth-of-focus (EDOF) IOL and a diffractive trifocal IOL. Methods A total of 20 patients who underwent bilateral implantation of AT LISA tri 839MP (Group 1) and 20 patients who had a mix–match implantation of AT LARA 829MP in the dominant eye and AT LISA tri 839MP in the nondominant eye (Group 2) were evaluated. Uncorrected distance (4 m), intermediate (60 cm and 80 cm), and near (40 cm) visual acuity, as well as CS, defocus curve, and responses to the patient questionnaires, were evaluated. Results Eighty eyes of 40 patients were included. Uncorrected distance and near visual outcomes were similar between the groups (p > 0.05). Group 2 showed significantly better intermediate visual outcomes at 60 cm and 80 cm than Group 1 (p < 0.05). Group 2 showed significantly better CS outcomes (photopic and mesopic) than Group 1 (p < 0.05). There was no significant difference between the groups regarding defocus curves from + 0.00 D to − 2.00 D, but a significant difference was shown from − 2.00 D to − 4.00 D. Patients’ satisfaction was significantly higher in Group 2 for driving at night (p < 0.05). Conclusions Both groups showed an effective visual performance. Group 2 exhibited better photopic and mesopic CS. The combination of EDOF and trifocal IOL seems to be a good option with a comfortable vision at all distances and less adverse visual phenomena.


  • Open Access

    The Relationship between Retinal Ganglion Cell Damage with Duration of Diabetes and Diabetic Retinopathy Status

    by Burcu Nurözler Tabakcı

    The aim of this study is to ascertain whether diabetes mellitus (DM) affects the macular GCIPL thickness in patients who have Nonproliferative Diabetic Retinopathy (NPDR) or no DR using Cirrus HD-OCT and to consider the relationship between GCIPL measurements and age, sex, duration of diabetes, DR status, glycated hemoglobin (HbA1c) level, Hypertension (HT) duration, and hypertensive retinopathy status.


  • Open Access

    Corticosteroid Treatment in Diabetic Macular Edema

    by Burcu Nurözler Tabakcı, Nurten Ünlü

    Diabetic macular edema is the most common cause of visual impairment in patients with diabetes mellitus. The pathogenesis of macular edema is complex and multifactorial. For many years, laser photocoagulation has been considered the standard therapy for the treatment of diabetic macular edema; however, few patients achieve significant improvements in visual acuity. Today the intravitreal administration of anti-inflammatory or anti-angiogenic agents together with the use of laser photocoagulation represents the standard of care for the treatment of this complication. The intravitreal route of administration minimizes the systemic side effects of corticosteroids. Steroid-related ocular side effects are elevated intraocular pressure and cataract, while injection-related complications include endophthalmitis, vitreous hemorrhage, and retinal detachment. In order to reduce the risks and complications, intravitreal implants have been developed recently to provide sustained release of corticosteroids and reduce repeated injections for the management of diabetic macular edema. In this review, the efficacy, safety, and therapeutic potential of intravitreal corticosteroids in diabetic macular edema are discussed with a review of recent literature.